A panel of experts advising the U.S. Centers for Disease Control and Prevention on vaccines will not convene for its February ...
The story has been updated to correct the FDA approval date to Friday, February 14 On Friday, February 14, the FDA approved ...
The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...
Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...
Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).
Pfizer’s two-year run with the only 5-in-1 meningococcal vaccine on the U.S. market has come to an end. Now, GSK is ready to ...
A Centers for Disease Control and Prevention vaccine advisory committee meeting scheduled for next week — the first since ...
22h
Tampa Free Press on MSNRFK Jr. Shakes Up HHS: Vaccine Ads Pulled, Key Panel Delayed In First Week As SecretarySecretary Robert F. Kennedy Jr. has made waves during his first week in office, pulling promotional vaccine ads and ...
2d
Medpage Today on MSNReport: RFK Jr. Planning to Remove Advisors on Vaccine CommitteeHHS Secretary Robert F. Kennedy Jr. appears to be planning major changes to the way his department oversees vaccines, media ...
The Advisory Committee on Immunization Practices (ACIP) meeting will be postponed to allow public comment prior to the ...
The FDA approved GSK’s pentavalent meningococcal vaccine to protect children and young adults aged 10 to 25 years against ...
The CDC’s Advisory Committee on Immunization Practices is expected to provide recommendations on the appropriate use of Penmenvy at its meeting on February 26, 2025. The Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results